International
Technological and
Industrial R&D Cooperation
Overview
Mina Goldiak, MSc
OCS - The Office of the Chief Scientist of
the Ministry of Economy is responsible
for implementing government policy
regarding support and encouragement of
industrial research and development.
“Heavier-than-air flying machines are impossible"
Lord Kelvin, 1895
“640 K Ought to be enough for
anybody "
Bill Gates, 1981
Some Facts about Israel:
•
•
•
•
•
•
•
•
•
Population
~ 8 million
Area
22,000 sq km
Households
~ 1.9 million
Average Household ~ 3.6 persons
GDP
$B140.6
GDP/Capita
$24,600
Inflation
3%
Unemployment
<7%
Growth Rate
2.7-3.5%
Expenditure on Civilian R&D as a percent of the
GDP in Israel and in OECD Countries
5
4.6
4
3.6
3.2
3
2
3.0
2.7
2.42.4 2.3
2.2 2.1
2.0 2.0 1.9
1.8
1.61.6 1.6
1
0
Source: Ministry of finance
1.4 1.4 1.3
1.1 1.0
0.9 0.8
0.70.7
Scientists & Technicians per 10,000 Workers
140
140
120
100
83
80
80
60
60
55
55
45
43
40
33
33
32
25
20
0
Israel
US
Japan
Germany Canada Switzerland Taiwan
UK
Ireland
Italy
Singapore
Spain
Israel’s Competitive Edge
Business Expenditure On R&D ( % GDP)
1st
Total Expenditure On R&D ( % GDP)
1st
Entrepreneurship
2nd
Skilled Labor
4th
Venture Capital
5th
Flexibility And Adaptability
6th
Source: IMD World Competitiveness Yearbook 2012
Patents (2008)
• Israel ranked #1 in
Medical Device
patents per capita
• Israel ranked #5 in
number of patents per
capita
Source: The United States Patent and
Trademark Office (June 2008)
“If you want real growth,
you have to have new
technologies”
Source: Business Week
OCS Grants by Technological Sectors 2012
No. Of Applications:
~ 2000 Projects
Requested Budget:
~ 6.7 Billion NIS
Total Grants:
~ 1.57 Billion NIS
Government Support Programs
Pre-Seed
Generic R&D Competitive R&D
Tnufa
Magnet
Technological
Incubators
Magneton
Nofar
Long-Range
R&D
Cooperative R&D
Industrial
R&D
Seed Fund
International
Bi-national Funds
ISERD
(Europe FP)
Applied Academic
Research
Basic R&D
Bi-national Agreements
EUREKA
Galileo
Global Enterprises
R&D Cooperation
Market Proximity
Technological Incubators
Pre-Seed & Seed R&D
2012 Budget – NIS 180 M
 A framework for nascent companies to develop
their innovative technological ideas into start-ups
that can attract private investors
 Suitable facilities for R&D activity & administrative
and logistic support to projects

24 Incubators
2 Industrial Incubators
1 Biotechnology incubator
8-10 projects in each
Grants- up to 85%
Magnet
Generic R&D






2012 Budget – NIS 181 M
Supports consortia of industrial companies
and academic institutions.
Target: jointly develop generic, pre
competitive technologies or dissemination
existing new technologies.
The technology cannot be acquired from
commercial sources at competitive prices
Grants of up to 66% - no royalty repayments
Magneton, Nofar, Nataf, Katamon
R&D Fund
Competitive R&D






2012 Grants – NIS 1070 M, ~2000 requests per
year
Supports competitive R&D of mature
companies (SME’s as well as big companies)
Target: establish and develop substantial
industrial R&D infrastructure
Grants between 30-50% of R&D plan, royalties
payments - obligatory upon success
Acquisition and transfer of knowledge due to
special approvals
Budgetary platform for all bilateral parallel
agreements
Government Support Programs
Pre-Seed
Generic R&D Competitive R&D
Tnufa
Magnet
Technological
Incubators
Magneton
Nofar
Long-Range
R&D
Cooperative R&D
Industrial
R&D
Seed Fund
International
Bi-national Funds
ISERD
(Europe FP)
Applied Academic
Research
Basic R&D
Bi-national Agreements
EUREKA
Galileo
Global Enterprises
R&D Cooperation
Market Proximity
International Cooperation
Foundations:
BIRDF-with U.S.A.
USISTC/F
SIIRD-with Singapore
CIIRDF - with Canada
KORIL-RDF - With S. Korea
MATIMOP encourages participation in
the many international programs for bi–
lateral and multi-lateral cooperation in
industrial R&D , signed and funded by the
Office of the Chief Scientist (OCS) of the
Ministry of Economy.
Ministry of
Economy)
Office of the
Chief Scientist
Bi-National Support Agreements
Europe
North America
New York
Maryland
Virginia
Wisconsin
Colorado
Massachusetts
Oregon
Ontario
South America
Argentina
Uruguay
Brazil
France
Russia
Italy
Germany
Greece
Denmark
Hungary
Turkey
Portugal
Finland
Sweden
Czech Republic
Netherlands
Lithuania
Slovenia
Cyprus
Bulgaria
Trento (Italy)
Asia
India
China
Jiangsu Province
Shanghai
Shenzhen
Shandong Province
Australia
Victoria
VISTECH: Victoria-Israel Science & Tech R&D Fund
The Victoria-Israel Science and Technology R&D Fund (VISTECH)
promotes, facilitates and supports cooperative science and
technology research and development (R&D) projects between
Israeli and Victorian Companies
Program is based on an MOU between Israel’s Ministry of Economy
(formerly Ministry of Industry, Trade and Labor) and the Government
of Victoria, signed in February 2005
Program launched in December 2005 with first Call for Proposals
Implemented through:
In Israel
MATIMOP, through the Office
of the Chief Scientist (OCS) of
the Ministry of Economy
In Victoria
The Department of State
Development, Business and
Innovation at Government of
Victoria




VISTECH: Victoria-Israel Science & Tech R&D Fund
Next Call For Proposals:
Sept/Oct 2013
VISTECH Activities:
Partner-matching - Matching companies in one state seeking a 
partner in the other
Support Activities - B2B events and activities promoting and 
marketing the benefits of joint, market oriented Victorian-Israeli
R&D collaboration
Funding - Supporting joint R&D projects by contributing up to 50% 
of the joint eligible R&D costs, based on local funding rules:
Funding in Victoria
Funding in Israel
-
Up to 50% of the approved R&D
expenses
Soft loan/conditional grant
Funding provided through the
Office of the Chief Scientist’s R&D
Fund
-
Details of funding to be
announced
Up to 50% of the approved R&D
expenses

VISTECH: Victoria-Israel Science & Tech R&D Fund
FOR MORE INFORMATION:
In Israel:
In Victoria:
Hadas Kroitoru
Program Manager
Gerry Roe
VISTECH
MATIMOP – The Israeli Industry
Center for R&D
Program Manager
S&T Programs
Department of State
Development, Business and
Innovation, Gov. of Victoria
Phone: 972 3 511 8117
Phone: (03) 9651 9182
Hadas@matimop.org.il
Gerry.Roe@dbi.vic.gov.au

VISITS - Victoria-Israel Science Innovation and Technology Scheme
The Victoria-Israel Science Innovation and Technology Scheme
(VISITS) launched in May 2013 by Gov. of Victoria (Dept. of State
Development, Business and Innovation) to support Victorian-Israeli
cooperation
VISITS builds on the outcomes of the VISTECH program (running since
2005) - Following a review of the program, additional support streams
for Australian companies have been introduced to form the VISITS
program:
VISTRADE: Trade Missions - VISTRADE supports the organization and
management of Australian trade missions to Israel, run by the Australia-Israel
Chamber of Commerce (AICC)
Support
VISTRIP: Victoria-Israel Trade and International Partnering - VISTRIP provides
ONLY to
Victoriangrant assistance for eligible Victorian organizations to attend recognized trade
Entities
missions, conferences and meetings in Israel
VISFPC : Victoria-Israel Feasibility and Proof of Concept - VISFPC provides
assistance of up to $50,000 to Victorian organizations to collaborate on
feasibility and /or proof of concept studies with Israeli organizations (not open
for applications yet)
Support VISTECH: Victoria-Israel Science and Technology R&D Fund – VISTECH supports
to Both
collaborative R&D projects by Victorian and Israeli organizations whose
Victorian
technologies have commercial applications (not open for applications yet)
& Israeli
Entities






International Cooperation Models
Multi-National Agreements
The European FP7
EUREKA
EUREKA Program
 European inter-governmental framework for 40
R&D national programs directed to support
industrial innovation
 Approves yearly 300 industrial R&D projects with
total budget of €1.5 B
 Israeli companies participate in 40 cooperation
projects a year – more than 10% of total activity
 Israel was the chairmanship for 2010-2011
Integrated Model – Total Returns to the Economy
Technological
Intensity
Hi-Tech
Mid-High Tech
Mid-Low Tech
Low-Tech
Derived
Own
Effect
10.9
17.3
38.4
39.1
Total
Spillover Value Added
Return On
Effect Increment to the Gov. Money
Economy
17.7
25.3
32.8
7.3
28.6
42.6
71.2
46.4
473%
751%
1323%
828%
Global Enterprise R&D Collaboration
24 Multinational from all over the world:
Abbott
Alcatel-Lucent
Arkema
B. Braun
BT
Coca-Cola
DuPont
GE
HP
IBM
Infosys
Intel
Life Technologies
Merck
Microsoft
Novozymes
Oracle
Philips
Posco
Procter & Gamble
Renault
Telecom Italia
Bombardier
Transportation
Deutsche
Telekom
$6M granted to >80 Joint Projects
(since launching the program in 2005)
Argo Medical invented the external
wearable skeleton enabling the
walking of paraplegic patients.
 TNUFA grantee
 Technological Incubator graduate
 BIRD joint project with Allied Orthotics
& Prosthetics
“It’s not the strongest of the
species that survives, nor the
most intelligent; it is the one that
is most adaptable to change”
Charles Darwin
Charles Darwin
For More Detailed Information
Mina Goldiak, Msc
Deputy Chief Scientist
International R&D Relations and Cooperation
29 Hamered Street
Tel Aviv 61500, Israel
Tel: +972 (3) 511 81 75
Fax: +972 (3) 517 76 55
Email: minag@matimop.org.il